WO2008025945A1 - Fluidic indicator device - Google Patents
Fluidic indicator device Download PDFInfo
- Publication number
- WO2008025945A1 WO2008025945A1 PCT/GB2007/003091 GB2007003091W WO2008025945A1 WO 2008025945 A1 WO2008025945 A1 WO 2008025945A1 GB 2007003091 W GB2007003091 W GB 2007003091W WO 2008025945 A1 WO2008025945 A1 WO 2008025945A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flow path
- liquid
- assay device
- test
- region
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
- G01N33/54389—Immunochromatographic test strips based on lateral flow with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0621—Control of the sequence of chambers filled or emptied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/148—Specific details about calibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/02—Identification, exchange or storage of information
- B01L2300/025—Displaying results or values with integrated means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502723—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by venting arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
Definitions
- the invention relates to a fluidic device for the passage of a liquid. It also relates to an assay device suitable for measurement of the amount and/or presence of. an analyte in, or property of, a fluid sample.
- EP291194 discloses an assay device comprising a lateral flow porous carrier wherein accumulation of a particulate labelled binding reagent in a detection zone provides a visible signal to the user of the presence or absence of analyte in a liquid sample. The signal however requires interpretation by the user.
- Digital devices have been developed as a consequence wherein on-board optics are able to measure the presence or intensity of the labelled reagent and provide an absolute answer which does not require interpretation. Digital devices however are expensive to produce as they require in addition to the optical components, a power source further processing electronics and a digital display.
- US4963498 discloses a microfluidic device for the measurement of an analyte in, or property of a fluid sample wherein reagents present in the device affect the flow rate of the sample.
- the device may comprise both a test capillary and a reference or control capillary.
- EP456699 discloses an apparatus for testing the presence of a substance in a liquid comprising a sample application port connected to a number of fluid conduits upstream from respective indicator chambers. According to an example, agglutination reagents present in the fluid conduits interact with the sample in order to change its flow rate, for example, preventing the liquid from reaching an indicator chamber within the time frame of the assay.
- a capillary device for testing for the presence of a substance is also disclosed by WO2004/083859.
- the device works by causing agglutination of a liquid sample in a test capillary in the presence of an analyte of interest (typically, human chorionic gonadotrophin, hCG), which agglutination prevents the flow of liquid sample in the test capillary but not in a control capillary (which contains no agglutination reagents).
- analyte of interest typically, human chorionic gonadotrophin, hCG
- hCG human chorionic gonadotrophin
- a problem associated with non-digital assay devices is that they provide an assay result as a signal of variable strength, which can require a degree of interpretation. This leaves the assay result open to misinterpretation, especially where the user or reader of the assay device has a preferred assay result in mind.
- some testing devices such as a pregnancy- testing device
- the present invention provides, in preferred embodiments a simpler method of providing a binary outcome assay device which is far simpler to produce than existing optical/electronic assay devices.
- the invention provides a fluidic assay device for assaying at least one property of a liquid sample, the device comprising:
- junction region at which the test flow path and the reference flow path contact one another, the junction region typically comprising an outlet, conduit, chamber or other portion which permits the onward flow of liquid;
- the test flow path and/or the reference flow path may comprise or consist of a microfluidic channel, a porous carrier, or a combination of the two.
- Preferred porous carriers include nitrocellulose and filter paper.
- the microfluidic channel is preferably of capillary dimensions such that a typical sample liquid is able to flow along the channel by capillary flow.
- the test and/or reference flow paths comprise or consist of channels having at least a portion with a capillary dimension.
- Typical microfluidic channels have an internal cross-sectional dimension of between 0.1 and 500 ⁇ m, more typically between 1 and lOO ⁇ m.
- the microfluidic channels may be formed from synthetic plastics materials such as polycarbonate, epoxy resin etc. , glass or metal.
- the channels may be formed by etching, casting, moulding etc. using conventional techniques.
- the property of the liquid sample which is assayed comprises the presence and/or amount of an analyte of interest.
- the analyte of interest may comprise, for example, a steroid, a hormone, a peptide or ..polypeptide, a carbohydrate, a lipid, a lipoprotein, a polynucleotide, an enzyme, a blood group marker, a disease marker, a diagnostic or prognostic indicator, a cation, an anion, or a molecular complex such as a virus, bacterium, yeast, fungus, spore or eukaryotic cell.
- the analyte of interest comprises hCG.
- the analyte is glucose.
- a property of a liquid sample that may be determined may be for example a coagulation property of blood or plasma such as prothombin time, partial activated thromboplastin time, thrombin time, and activated clotting time.
- the assay device may comprise a control, wherein the control is capable of generating a signal which indicates that sample has been correctly applied to the sample application region and that the assay device is working normally.
- the control may comprise a control flow path having one or more reagents therein.
- the reference flow path may also act as a control.
- control flow path is such that sample liquid applied to the sample application region will flow along the flow path and typically to an indicator region, either upstream or downstream of the junction region and there generate a signal, typically a visible signal.
- the test flow path will generally be substantially similar in character to the reference flow path, but will typically comprise one or more reagents or binding partners which will react with or bind to the analyte of interest. Preferably such reaction or binding event has the effect of altering (typically decreasing) the rate of flow of sample liquid along the test flow path.
- the device of the invention can readily be configured to assay for the presence and/or amount of two or more analytes of interest by providing a two or more test flow paths and, optionally, a corresponding number of reference flow paths.
- a separate sample application port or input is provided in the sample application region for each test flow path.
- the sample application region comprises a common sample application port or input, such that sample liquid applied thereto may flow into two or more flow paths (e.g. two or more test flow paths; or. at least a test flow path and a reference flow path).
- the device comprises a common sample application port or input which supplies sample liquid to all flow paths present in the device, such that a single sample application step is sufficient to initiate the assay.
- the liquid sample may be any suitable liquid, such as water, sewage sample, or an aqueous extract (e.g. an aqueous food or drink sample) or a biological sample e.g. blood, plasma, serum, urine, pus, sweat, saliva, vaginal fluid, or tears.
- a preferred sample is urine.
- the liquid sample may be applied to the device 'neat' or may be subjected to a pretreatment step (e.g. including one or more of the following: mixing; agitation; sonication; dilution; incubation; denaturation; or reaction with one or more reagents).
- Performance of the assay conveniently comprises reacting or interacting the sample with one or more substances which have the capacity to affect the rate of flow of liquid sample along the test flow path in order to provide an indication or measure of the presence and/or amount of an analyte in, or other property of, the fluid sample.
- the substances will be provided within the assay device, but additionally or alternatively one or more such substances may be mixed with the sample prior to application of the sample to the assay device.
- reaction or interaction of the substance(s) with the sample will tend to alter (i.e. increase or decrease) the rate of progress of sample along the test flow path.
- the substance(s) may be such as to increase the rate of flow of sample liquid along the test flow path if the sample comprises an analyte of interest above a certain ⁇ nimum detectable concentration. More preferably however the effects of the substance(s) are such as to impede or decrease the rate of flow of sample liquid along the test flow path if the sample comprises the analyte(s) of interest.
- the device comprises one or more reagents which react with, or binding partners which bind to, the analyte(s) of interest.
- Convenient binding partners comprise antibodies or antigen-binding fragments thereof (such as Fab, Fv, scFv, domain antibodies and the like), or multimers of antibodies or antigen-binding fragments thereof.
- binding partners may comprise, for example, biotin, streptavidin, complementary polynucleotides (comprising
- Receptors include both prokaryotic and eukaryotic polypeptides, numerous examples of which (both full length and truncated) are known.
- the reagents or binding partners may be immobilised on the assay device (i.e. remain attached during performance of the assay) or may be releasably attached (i.e. are released from a support during performance of the assay), or may comprise a combination of immobilised and releasably attached reagents or binding partners.
- a releasably attached binding partner is provided on a porous carrier located at an upstream portion of the test flow path.
- an immobilised binding partner is provided in the test flow path.
- a releasably attached binding partner is provided (on a porous carrier or otherwise) at a relatively upstream portion of the test flow path and an immobilised binding partner is provided at a relatively downstream portion of the test flow path.
- Methods of releasably attaching or of immobilising antibodies and the like on surfaces are well known to those skilled in the art.
- a binding partner is provided within a capillary channel forming part of the test flow path.
- the binding partner or reagent may advantageously be labelled. Suitable labels include, but are not limited to, an enzyme, a fluorescent dye, a coloured dye and a particle of colloidal gold or other colloidal metal.
- the presence of analyte may cause an increase in the flow rate of fluid in the test channel.
- binding of an analyte may cause displacement of a species which is conjugated to a detergent, the presence of which in the fluid channel results in an increase in flow rate of the sample.
- the binding partner is particulate or comprises a particulate substance.
- the binding partner comprises a latex particle or a particle of colloidal gold or other metal.
- the particle comprises a plurality of binding partner molecules, such that a single particle may simultaneously be bound to a plurality of members of the analyte of interest.
- the latex particle is loaded or marked with a direct visual label, such as a coloured dye.
- the binding partner or partners are such that an agglutination reaction occurs in the test flow path in the presence of the analyte of interest, which agglutination reaction serves to retard or inhibit the flow of sample liquid along the test flow path.
- the effect of such retardation or inhibition of flow along the test flow path is that liquid flowing along the reference or control path will reach the junction region first, which in turn blocks the further advance of liquid along the test flow path (as explained below).
- test flow path may comprise a reagent such as thromboplastin, or one or more of the various clotting factors, for the determination of a coagulation property of blood or plasma.
- a reagent such as thromboplastin, or one or more of the various clotting factors, for the determination of a coagulation property of blood or plasma.
- the reagent may be Concanavalin A which is able to react with glucose to cause an increase in viscosity in the fluid sample.
- the test flow path may comprise a solvent swellable polymer gel which swells in me presence of a particular solvent to cause an increase in viscosity.
- a dextran polymer when the analyte to be detected is water.
- the assay device of the present invention can be thought of as using a "race” between the liquid flowing along the test flow path and that flowing along the reference flow path - the first liquid to reach the junction region will win the "race” and block further advance of liquid along the other flow path.
- One way of forming the block is to provide a number (one or more) of vents downstream of the junction region. Displacement of the gas (typically air) filling the microfluidic channel of the test and flow paths, via these vents, is necessary to allow liquid to advance along the flow paths. However, once liquid from one of the flow paths has reached the junction it prevents the venting of gas from the other flow path, forming a gas block
- test and reference flow paths may additionally comprise partial barriers to flow, such as constrictions, filters, weirs or the like, which encourage the formation of more total barriers or obstructions in the presence of e.g. an agglutination reaction.
- partial barriers to flow such as constrictions, filters, weirs or the like, which encourage the formation of more total barriers or obstructions in the presence of e.g. an agglutination reaction.
- a partial barrier or obstruction is provided in the one or more test flow paths but not in the reference flow path.
- the device conveniently comprises at least one indicator region.
- the indicator region comprises a display which displays information about the assay result to a person using the assay device. Typically the assay result is displayed, at least in part, by a colour change.
- an indicator region downstream of the junction region.
- dyes of different colours are provided in the respective test and control flow paths, such that the presence of a dye of a particular colour in the indicator region reveals by which route (the test or control flow path) liquid first reached the indicator region.
- two different enzymes e.g. horseradish peroxidase and glucose oxidase
- a respective substrate for one of the enzymes could be provided in the flow paths which, reacts, in the presence of the relevant enzyme catalyst, to produce a coloured product.
- The. colour of the product reveals which substrate was introduced into the indicator region (and hence by which flow path liquid first arrived there).
- the indicator region (if located downstream of the junction region) may comprise components of two different signal- generating means which generate detectably different signals, with one or more further components of each signal-generating means being mobilisably disposed upstream, the further component of one signal-generating means being disposed in the test flow path, and the further component of the other signal-generating means being disposed in the reference flow path, the further component being required to contact the other component in the indicator region in order to generate a signal.
- Which of the two signal-generating means is activated depends on which of the further components reaches the indicator region first, which in turn depends on the relative rates of flow of liquid along the test and reference flow paths.
- the indicator region comprises a pH-sensitive indicator
- the test and reference flow paths each comprise a different pH-affecting agent e.g. one comprises a buffer at relatively acidic pH and one comprises a buffer at relatively alkaline pH.
- the flow path by which liquid first reaches the indicator region will therefore determine the pH in the indicator region and hence the colour of the indicator.
- Embodiments of this general type with a downstream indicator region, have the advantage that it is not necessary to impede or retard the flow of liquid along the test flow path by a large amount in order for the liquid flowing along the reference flow path to reach the indicator region first - a time differential of as little as 1 or 2 seconds will suffice.
- an indicator region is provided, upstream of the junction region, in each of the reference and the test flow paths.
- flow of liquid along the reference flow path to a certain point acts to block flow of liquid along the test flow path before the liquid reaches the indicator region on the test flow path, such that a certain assay result is displayed in the indicator region.
- an indicator substance such as a dye
- upstream of the indicator region such that a visible change can be seen if/when liquid reaches the indicator region of the test and/or reference-)- flow paths.
- the indicator region comprises a microfluidic channel, such as a capillary, which is visible to a user (e.g. through a window or aperture in an otherwise opaque housing).
- the indicator region comprises two channels or capillaries, one forming part of the test flow path and one forming part of the reference flow path.
- the microfluidic channels or capillaries in the indicator region became filled with a coloured liquid during performance of the assay.
- the colour of the liquid may itself indicate the result of the assay.
- the coloured liquid may simply serve to alter the visibility of the channel or capillary. For example, a clear plastics or glass capillary against a clear or white background may not be readily apparent.
- a coloured liquid into such a channel or capillary will increase contrast and render the channel or capillary readily visible.
- the channel or capillary is initially of high contrast with its background (e.g. a white capillary against a red background)
- introduction of a coloured liquid into the channel or capillary which is of the same colour as the background will reduce the contrast and render the capillary or channel difficult to observe.
- the indicator region may comprise one or more channels or capillaries which form one or more words or symbols (such as "PREGNANT", or a plus or minus symbol).
- one flow path comprises an indicator region in which a channel or capillary forms the word "NOT”
- another flow path comprises an indicator region in which a channel or capillary forms the word "PREGNANT”.
- the word “NOT” is formed in the test flow path
- the word “PREGNANT” is formed in the reference flow path. If a sample is applied the device which does not contain any hCG (i.e. the subject is not pregnant), liquid is free to flow along both the test and reference flow paths.
- a coloured label e.g. a dye
- a coloured label e.g. a dye
- agglutination reagents e.g. particles of latex coated with anti-hCG antibodies
- the assay device it may be preferred to bias the assay device, so as to configure the device such that liquid flowing along the reference flow path will, in the absence of analyte of interest in the sample, reach the junction region slightly before the liquid flowing along the test flow path.
- This feature applies particularly, but not exclusively, to those embodiments in which an indicator region is provided downstream of the junction region, and in which, for example, the test and reference flow paths are provided with a respective indicator or label. If the times taken for the liquid sample to reach the junction region via the reference flow path and the test flow path were identical, it is at least conceivable that liquid from both flow paths would reach the junction region exactly simultaneously and hence become mixed in the indicator region, which would fail to provide a clear assay result. This can be avoided by making the reference flow path shorter and/or by making the rate of flow along the reference flow path more rapid (e.g. by using a thinner bore capillary).
- the invention provides a method of testing for the presence of an analyte of interest in a liquid sample, the method comprising the step of applying the liquid sample to the sample application region of a device in accordance with the first aspect of the invention; and noting or recording the assay result displayed by the device.
- the invention provides a method of making an assay device in accordance with the first aspect of the invention, comprising assembling the necessary elements in an operable relationship.
- FIGS 1 and 2 show schematic representations of different embodiments of an assay device in accordance with the present invention.
- Figure 1 shows a device according to .the invention.
- the device has a sample application region 2 fmidicaUy connected to test flow path 4 and a reference flow path 6, which both comprise a capillary channel.
- a filter 8 may optionally be provided in one or both of the flow paths.
- the flow paths converge downstream at a junction region 10 leading to a common channel 12.
- An indicator region 14 may be provided downstream from the junction region 10.
- Liquid sample applied to the device via a sample application port in the sample application region 2 is able to flow respectively along the test and reference flow paths 4, 6 and towards the junction region 10.
- One or more vents are provided in the common channel 12 and the indicator region 14 to allow air to be displaced from the device by the advance of liquid along the capillaries. However, once one of the fluid fronts has reached the junction region 10, it blocks off the other flow path from the vents, preventing further advance of the liquid along the other flow path.
- An indication means may be provided in the fluid channels to enable an observer to determine which fluid in the respective channel arrived first.
- dyes of different colours may be provided in each channel such that the fluid sample is able to interact with the dye to produce liquid of a particular colour.
- the presence of a particular coloured dye in the indicator region would enable a user to determine which fluid reached the fluid gate first.
- a base layer was prepared from agarose coated 200 ⁇ m polyester (GelBond, BMA).
- the appropriate microfluidic features were cut out of a 75 ⁇ m thick heat sealing adhesive PE layers using a GraftTeC cutter and the two layers laminated together.
- Finally a third layer was laminated to the intermediate layer to provide microfluidic channels of 75 ⁇ m.
- the assay device comprises a sample application port in a common sample application region 2, from which liquid sample can flow into a capillary forming part of the test flow path 4 and a separate capillary forming part of the reference flow path 6.
- each flow path may be provided with a unique, separate sample application region.
- the assay device described in the present examples may be provided with further test flow paths to test for the presence of further analytes of interest.
- the or each further test flow path can, if desired, be provided with a corresponding reference flow path.
- each flow path comprises a filter element 8 and an indicator region 14, upstream of a junction region 10.
- the filer element 8 comprises one or more binding partners for the analyte of interest, in this instance hCG.
- the binding partner particles coated with anti-hCG monoclonal antibody, mediates an agglutination reaction.
- Each flow path is also provided with a coloured dye which is mobilised by contact, and migrates, with the liquid sample.
- the indicator region 14 of each flow path comprises a capillary channel forming the word "NOT” in the test flow path 4 and the word “PREGNANT” in the reference flow path.
- These capillaries are formed from clear synthetic plastics material and are against a low contrast background (e.g. white or clear synthetic plastics material). Accordingly, prior to performance of the assay, the capillaries are not highly visible.
- Vents may be provided at several points along the reference flow path to encourage the flow of liquid therealong. In particular these vents may be provided to assist the liquid in filling the indicator region of the reference flow path.
- vents in the test flow path air being vented from the test flow path capillary 4 only via one or more vents downstream of the junction region 10, in the common channel 12, such that if liquid flowing along the reference flow path 6 reaches the junction region 10 before the liquid front flowing along the test flow path 4, air can no longer be displaced from the test flow path capillary and further advance of the liquid along that channel is prevented.
- the rate of flow of liquid along the test and reference flow paths, and/or the length of the respective flow paths, is adjusted such that, in the absence of hCG, liquid flows along both flow paths 4, 6 and fills the respective indicator regions.
- the liquid flowing along the reference flow path will reach the junction region 10 either simultaneously with the liquid flowing along the test flow path or just 1 or 2 seconds in advance thereof.
- the applied sample comprises hCG
- agglutination will take place in the test flow path 4 which substantially retards the advance of liquid along the test flow path capillary towards the indicator region. This allows liquid flowing along the reference flow path to "win the race” to the junction region easily.
- the liquid flowing along the reference flow path reaches the junction region 10 before the liquid flowing along the test flow path 4 reaches the indicator region.
- the word “NOT” does not become filled with dye and remains indistinct, whilst the word “PREGNANT” becomes highly visible and thus displays the assay result.
- a microfluidic device was prepared having a sample application port provided upstream from a fluid channel of dimensions, 5mm wide by 3cm long by lOO ⁇ m in height. Provided at a distance of 2cm along the fluid channel was a filter zone of 5mm in length comprising channels running parallel to the fluid channel having a 30 ⁇ m gap.
- test solution took 60s to reach the end of the channel.
- reference fluid took just 10s.
- the delay in flow of the test fluid was due to the agglutinated particles becoming stuck in the filter zone. In the case of the reference fluid, no agglutination took place and therefore the fluid is able to flow unimpeded.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2661065A CA2661065C (en) | 2006-08-30 | 2007-08-14 | Fluidic indicator device |
CN200780038590.5A CN101528350B (en) | 2006-08-30 | 2007-08-14 | Fluidic indicator device |
JP2009526157A JP5263624B2 (en) | 2006-08-30 | 2007-08-14 | Fluid indicator device |
AU2007291058A AU2007291058B2 (en) | 2006-08-30 | 2007-08-14 | Fluidic indicator device |
EP07789214.9A EP2056965B9 (en) | 2006-08-30 | 2007-08-14 | Fluidic indicator device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0617035.1 | 2006-08-30 | ||
GBGB0617035.1A GB0617035D0 (en) | 2006-08-30 | 2006-08-30 | Fluidic indicator device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008025945A1 true WO2008025945A1 (en) | 2008-03-06 |
Family
ID=37137002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/003091 WO2008025945A1 (en) | 2006-08-30 | 2007-08-14 | Fluidic indicator device |
Country Status (8)
Country | Link |
---|---|
US (3) | US20080076190A1 (en) |
EP (1) | EP2056965B9 (en) |
JP (1) | JP5263624B2 (en) |
CN (1) | CN101528350B (en) |
AU (1) | AU2007291058B2 (en) |
CA (1) | CA2661065C (en) |
GB (1) | GB0617035D0 (en) |
WO (1) | WO2008025945A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2101917A1 (en) * | 2007-01-10 | 2009-09-23 | Scandinavian Micro Biodevices A/S | A microfluidic device and a microfluidic system and a method of performing a test |
WO2009125227A1 (en) * | 2008-04-12 | 2009-10-15 | Spd Swiss Precision Diagnostics Gmbh | Assay device comprising bubble-forming means |
US20100267065A1 (en) * | 2009-03-25 | 2010-10-21 | Timothy Robert Geiger | Apparatus and methods for analyzing fluid variables |
WO2012164263A1 (en) | 2011-06-01 | 2012-12-06 | Carclo Technical Plastics Limited | Capillary fluid flow measurment and capillary flow device therefore |
US9797896B2 (en) | 2013-02-12 | 2017-10-24 | Ortho-Clinical Diagnostics, Inc. | Reagent zone deposition pattern |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0617035D0 (en) * | 2006-08-30 | 2006-10-11 | Inverness Medical Switzerland | Fluidic indicator device |
US8222908B2 (en) * | 2010-02-16 | 2012-07-17 | Stratasys, Inc. | Capacitive detector for use in extrusion-based digital manufacturing systems |
EP2591358B1 (en) * | 2010-07-05 | 2016-09-07 | Koninklijke Philips N.V. | Examination system with sample incubation |
EP2916953B1 (en) * | 2012-11-08 | 2023-03-29 | Takara Bio USA, Inc. | Extraction of restrained liquid from wells |
US9386948B2 (en) | 2012-12-05 | 2016-07-12 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample transport |
US10248765B1 (en) | 2012-12-05 | 2019-04-02 | Theranos Ip Company, Llc | Systems, devices, and methods for bodily fluid sample collection, transport, and handling |
SG11201507325XA (en) | 2013-03-15 | 2015-10-29 | Theranos Inc | Methods and devices for sample collection and sample separation |
US20140323911A1 (en) * | 2013-03-15 | 2014-10-30 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
US10073069B2 (en) | 2013-04-23 | 2018-09-11 | Cordant Research Solutions, Llc | Systems and methods to determine body drug concentration from an oral fluid |
WO2015138343A1 (en) | 2014-03-10 | 2015-09-17 | Click Diagnostics, Inc. | Cartridge-based thermocycler |
CN103983769B (en) * | 2014-03-25 | 2015-11-18 | 中国海洋大学 | A kind of preparation method of nm of gold immunochromatography kapillary |
CN107429281B (en) | 2014-12-31 | 2022-05-27 | 维斯比医学公司 | Apparatus and method for molecular diagnostic testing |
US10371606B2 (en) | 2015-07-21 | 2019-08-06 | Theraos IP Company, LLC | Bodily fluid sample collection and transport |
WO2017044888A1 (en) | 2015-09-09 | 2017-03-16 | Theranos, Inc. | Methods and devices for sample collection and sample separation |
WO2017185067A1 (en) | 2016-04-22 | 2017-10-26 | Click Diagnostics, Inc. | Printed circuit board heater for an amplification module |
WO2017197040A1 (en) | 2016-05-11 | 2017-11-16 | Click Diagnostics, Inc. | Devices and methods for nucleic acid extraction |
USD800331S1 (en) | 2016-06-29 | 2017-10-17 | Click Diagnostics, Inc. | Molecular diagnostic device |
CN110325652A (en) | 2016-06-29 | 2019-10-11 | 易捷仪器诊断股份有限公司 | Use the device and method of flow cell detection molecules |
CA3029682A1 (en) * | 2016-06-30 | 2018-01-04 | Click Diagnostics, Inc. | Devices and methods for nucleic acid extraction |
USD800913S1 (en) | 2016-06-30 | 2017-10-24 | Click Diagnostics, Inc. | Detection window for molecular diagnostic device |
USD800914S1 (en) | 2016-06-30 | 2017-10-24 | Click Diagnostics, Inc. | Status indicator for molecular diagnostic device |
JP6819238B2 (en) * | 2016-11-21 | 2021-01-27 | 株式会社デンソー | Wiring abnormality detection device |
US11857966B1 (en) | 2017-03-15 | 2024-01-02 | Labrador Diagnostics Llc | Methods and devices for sample collection and sample separation |
US11162130B2 (en) | 2017-11-09 | 2021-11-02 | Visby Medical, Inc. | Portable molecular diagnostic device and methods for the detection of target viruses |
US11198128B2 (en) * | 2018-09-05 | 2021-12-14 | International Business Machines Corporation | Microfluidic device with array of chambers for encoding detectable information |
CN113167760B (en) * | 2018-12-02 | 2023-11-03 | 聚合物技术系统公司 | Systems and methods for electronic gate features in electrochemical test strips |
US11352675B2 (en) | 2020-01-03 | 2022-06-07 | Visby Medical, Inc. | Devices and methods for antibiotic susceptability testing |
US20210325386A1 (en) * | 2020-04-15 | 2021-10-21 | University Of Rochester | Microfluidic Devices and Methods for Rapid Detection of Pathogens and Other Analytes |
US11622886B2 (en) | 2020-05-18 | 2023-04-11 | Johnson & Johnson Surgical Vision, Inc. | Thermocouple coupled with a piezoelectric crystal for feedback on vibration frequency |
US11534752B2 (en) * | 2020-12-30 | 2022-12-27 | International Business Machines Corporation | Rapid test device having multiple heterogeneous diagnostic methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083859A1 (en) * | 2003-03-18 | 2004-09-30 | Platform Diagnostics Limited | Agglutination based sample testing device |
US20050255004A1 (en) * | 2004-04-29 | 2005-11-17 | Nan-Kuang Yao | Gravity-driven apparatus and method for control of microfluidic devices |
WO2006046054A1 (en) * | 2004-10-28 | 2006-05-04 | Platform Diagnostics Limited | Assay system |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963498A (en) | 1985-08-05 | 1990-10-16 | Biotrack | Capillary flow device |
JPH0746107B2 (en) | 1987-04-27 | 1995-05-17 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Test method |
US5275785A (en) * | 1987-10-30 | 1994-01-04 | Unilever Patent Holdings B.V. | Test device for detecting an analyte in a liquid sample |
GB8903046D0 (en) | 1989-02-10 | 1989-03-30 | Vale David R | Testing of liquids |
IE69047B1 (en) * | 1989-03-23 | 1996-08-07 | Gary Harold Gregory Hen Thorpe | Liquid transfer devices |
WO1993022058A1 (en) | 1992-05-01 | 1993-11-11 | Trustees Of The University Of Pennsylvania | Polynucleotide amplification analysis using a microfabricated device |
US5308775A (en) * | 1992-09-15 | 1994-05-03 | Abbott Laboratories | Assay devices for concurrently detecting an analyte and confirming the test result |
US6991762B1 (en) | 1996-04-26 | 2006-01-31 | Arkray, Inc. | Device for analyzing a sample |
US6074827A (en) | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
US5804436A (en) | 1996-08-02 | 1998-09-08 | Axiom Biotechnologies, Inc. | Apparatus and method for real-time measurement of cellular response |
US6090251A (en) | 1997-06-06 | 2000-07-18 | Caliper Technologies, Inc. | Microfabricated structures for facilitating fluid introduction into microfluidic devices |
US6521182B1 (en) | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6830934B1 (en) * | 1999-06-15 | 2004-12-14 | Lifescan, Inc. | Microdroplet dispensing for a medical diagnostic device |
US6637463B1 (en) | 1998-10-13 | 2003-10-28 | Biomicro Systems, Inc. | Multi-channel microfluidic system design with balanced fluid flow distribution |
GB9825992D0 (en) * | 1998-11-28 | 1999-01-20 | Moorlodge Biotech Ventures Lim | Electrochemical sensor |
US7040144B2 (en) | 2000-02-23 | 2006-05-09 | Caliper Life Sciences, Inc. | Microfluidic viscometer |
WO2001068238A2 (en) | 2000-03-14 | 2001-09-20 | Micronics, Inc. | Microfluidic analysis cartridge |
US6561208B1 (en) | 2000-04-14 | 2003-05-13 | Nanostream, Inc. | Fluidic impedances in microfluidic system |
US7524462B2 (en) | 2002-03-29 | 2009-04-28 | Agilent Technologies, Inc. | Capillary flow for a heterogenous assay in a micro-channel environment |
US7901939B2 (en) | 2002-05-09 | 2011-03-08 | University Of Chicago | Method for performing crystallization and reactions in pressure-driven fluid plugs |
US20040053315A1 (en) * | 2002-08-12 | 2004-03-18 | Caliper Technologies Corp. | Methods and systems for monitoring molecular interactions |
US7374546B2 (en) * | 2003-01-29 | 2008-05-20 | Roche Diagnostics Operations, Inc. | Integrated lancing test strip |
JP2006053090A (en) * | 2004-08-13 | 2006-02-23 | Alps Electric Co Ltd | Inspection plate and inspection method using it |
GB0617035D0 (en) * | 2006-08-30 | 2006-10-11 | Inverness Medical Switzerland | Fluidic indicator device |
EP2101917A1 (en) | 2007-01-10 | 2009-09-23 | Scandinavian Micro Biodevices A/S | A microfluidic device and a microfluidic system and a method of performing a test |
-
2006
- 2006-08-30 GB GBGB0617035.1A patent/GB0617035D0/en not_active Ceased
-
2007
- 2007-08-14 CN CN200780038590.5A patent/CN101528350B/en active Active
- 2007-08-14 CA CA2661065A patent/CA2661065C/en active Active
- 2007-08-14 EP EP07789214.9A patent/EP2056965B9/en active Active
- 2007-08-14 AU AU2007291058A patent/AU2007291058B2/en active Active
- 2007-08-14 JP JP2009526157A patent/JP5263624B2/en active Active
- 2007-08-14 WO PCT/GB2007/003091 patent/WO2008025945A1/en active Application Filing
- 2007-08-30 US US11/848,175 patent/US20080076190A1/en not_active Abandoned
-
2011
- 2011-09-27 US US13/246,104 patent/US8492136B2/en active Active
-
2013
- 2013-07-02 US US13/933,708 patent/US8980177B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083859A1 (en) * | 2003-03-18 | 2004-09-30 | Platform Diagnostics Limited | Agglutination based sample testing device |
US20050255004A1 (en) * | 2004-04-29 | 2005-11-17 | Nan-Kuang Yao | Gravity-driven apparatus and method for control of microfluidic devices |
WO2006046054A1 (en) * | 2004-10-28 | 2006-05-04 | Platform Diagnostics Limited | Assay system |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2101917A1 (en) * | 2007-01-10 | 2009-09-23 | Scandinavian Micro Biodevices A/S | A microfluidic device and a microfluidic system and a method of performing a test |
WO2009125227A1 (en) * | 2008-04-12 | 2009-10-15 | Spd Swiss Precision Diagnostics Gmbh | Assay device comprising bubble-forming means |
US9151749B2 (en) | 2008-04-12 | 2015-10-06 | Alere Switzerland Gmbh | Assay device comprising bubble-forming means |
US20100267065A1 (en) * | 2009-03-25 | 2010-10-21 | Timothy Robert Geiger | Apparatus and methods for analyzing fluid variables |
CN102483410A (en) * | 2009-03-25 | 2012-05-30 | 莱泽尔诊断公司 | Apparatus and methods for analyzing fluid variables |
US8481278B2 (en) * | 2009-03-25 | 2013-07-09 | Lyzer Diagnostics, Inc. | Apparatus and methods for analyzing fluid variables |
US20140024059A1 (en) * | 2009-03-25 | 2014-01-23 | Lyzer Diagnostics, Inc. | Apparatus and methods for analyzing fluid variables |
WO2012164263A1 (en) | 2011-06-01 | 2012-12-06 | Carclo Technical Plastics Limited | Capillary fluid flow measurment and capillary flow device therefore |
US9797896B2 (en) | 2013-02-12 | 2017-10-24 | Ortho-Clinical Diagnostics, Inc. | Reagent zone deposition pattern |
US9927436B2 (en) | 2013-02-12 | 2018-03-27 | Ortho-Clinical Diagnostics, Inc. | Reagent zone deposition pattern |
Also Published As
Publication number | Publication date |
---|---|
CA2661065A1 (en) | 2008-03-06 |
JP5263624B2 (en) | 2013-08-14 |
CN101528350A (en) | 2009-09-09 |
EP2056965B9 (en) | 2013-11-06 |
AU2007291058B2 (en) | 2014-03-06 |
US20080076190A1 (en) | 2008-03-27 |
EP2056965A1 (en) | 2009-05-13 |
US20140141501A1 (en) | 2014-05-22 |
JP2010501876A (en) | 2010-01-21 |
US8492136B2 (en) | 2013-07-23 |
GB0617035D0 (en) | 2006-10-11 |
AU2007291058A1 (en) | 2008-03-06 |
US20120122234A1 (en) | 2012-05-17 |
CA2661065C (en) | 2014-07-15 |
EP2056965B1 (en) | 2013-03-20 |
CN101528350B (en) | 2012-11-14 |
US8980177B2 (en) | 2015-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2056965B1 (en) | Fluidic indicator device | |
EP2673641B1 (en) | Reduced step dual path immunoassay device and method | |
US9151749B2 (en) | Assay device comprising bubble-forming means | |
US8614101B2 (en) | In situ lysis of cells in lateral flow immunoassays | |
US7459127B2 (en) | Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces | |
EP1768783B1 (en) | Controlled flow assay device and method | |
US6410341B1 (en) | Analytical test device and method for use in medical diagnoses | |
JP2002522767A (en) | Analytical test apparatus and method | |
JP2004536309A (en) | Lateral flow immunoassay device | |
US20080148822A1 (en) | Fluidic Gating Device | |
EP2313775A2 (en) | In situ lysis of cells in lateral flow immunoassays | |
EP0443231A1 (en) | Multi-layered diagnostic test device for the determination of substances in liquids | |
JP5139581B2 (en) | Analytical strip | |
ES2435545T3 (en) | A method to analyze a liquid | |
WO2006011249A1 (en) | Analytical apparatus and method of analysis | |
EP2835645B1 (en) | Lateral flow membrane and immunoassay device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780038590.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07789214 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007291058 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007789214 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2661065 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009526157 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2007291058 Country of ref document: AU Date of ref document: 20070814 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1871/DELNP/2009 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: RU |